Boston Collaborative Drug Surveillance Program Bcdsp

Boston Collaborative Drug Surveillance Program (BCDSP) is an independent, nonprofit research group with over 40 years of expertise in the design and conduct of pharmacoepidemiology and disease epidemiology research using existing data sources. We primarily use electronic health data collected in the United Kingdom and United States, combined with rigorous epidemiological and statistical methods, to produce real world evidence to support clinical, regulatory, and pharma decision making. The BCDSP makes significant and valuable contributions in the generation of real-world evidence in support of drug development programs, new drug applications, and post-marketing safety surveillance, as well as to inform public health and clinical decisions. We have extensive experience in the design and conduct of disease epidemiology studies to identify risk factors, describe disease progression and comorbidities, and in post authorization safety studies (PASS) to assess safety of newly marketed treatments. Studies conducted by our group cover a broad range of drugs and diseases. The BCDSP, over its 35-year association, has attained unparalleled knowledge of and made major contributions to the development and validation of the United Kingdom Clinical Practice Research Datalink (CPRD) and linked resources and also has broad experience with US claims and electronic health record databases. The BCDSP also offers professional education in drug epidemiology and welcomes collaborators from government, industry, and academia.